^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
ScreenFire HPV Risk Stratification Assay

Type:
CE Marked
Related tests:
Evidence

News

6ms
Analytical Validation of Near Point-of-Care Diagnostic Tests and Cost-Effective Swabs for the Detection of High-Risk Human Papillomavirus (ASM Microbe 2024)
Ongoing investigations include evaluating SteriPack nylon flocked swabs in a clinical trial comparing healthcare provider-collected vs self-collected swab specimens for hrHPV detection. In summary, our research showcases advancements in hrHPV near point-of-care assays, coupled with cost-effective swabs, representing a significant stride forward for hrHPV diagnostics in LMICs.
HEOR • Cost-effectiveness • Cost effectiveness
|
ScreenFire HPV Risk Stratification Assay • Xpert HPV Assay
9ms
AmpFire HPV and ScreenFire RS HPV validation trial. (PubMed, Am J Clin Pathol)
"The excellent intra- and interlaboratory reproducibility and the established clinical performance, together with the platforms' simplicity, make these assays particularly applicable to low-resource settings."
Journal
|
AmpFire HPV Assay • ScreenFire HPV Risk Stratification Assay • cobas® HPV test